Intrapartum stress and lipid status of term infants: relation to fetal adrenal production of dehydroepiandrosterone sulphate |
| |
Authors: | Tamula M. Patterson C. R. Parker Jr. |
| |
Affiliation: | 1. Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama, USAtamula.patterson@obgyn.uab.edu;3. Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama, USA |
| |
Abstract: | Objective. Evaluate the effect of acute intrapartum stress on umbilical cord plasma levels of cholesterol, triglyceride and dehydroepiandrosterone sulphate (DS) in term infants.Methods. Umbilical cord plasma levels of cholesterol, triglyceride and DS were measured in 176 infants that delivered ≥37 weeks' gestation. Eighty-eight infants experienced acute intrapartum stress while the remaining infants were non-stressed controls who were case-matched by gestational age and delivery method.Results. The umbilical cord plasma levels of cholesterol in the stressed infants (71.7 ± 16.1 mg/dL, mean ± SD) were similar to those of the control infants (70.9 ± 16.0 mg/dL). Triglyceride levels in stressed infants were significantly higher (p = 0.003) than those of control infants. Both stressed and control infants with increased triglyceride levels had normal DS levels; however, those with increased cholesterol levels had reduced umbilical cord plasma levels of DS. Stressed infants with increased cholesterol levels had significantly lower DS levels than control infants (p = 0.008).Conclusions. Intrapartum stress leads to increased fetal plasma levels of triglycerides; yet, cholesterol levels are usually unaffected. Infants with increased cholesterol levels also have reduced DS levels, suggesting that the rise in cholesterol was due to a reduction in fetal adrenal utilisation of plasma cholesterol as substrate for steroid formation. |
| |
Keywords: | Triglycerides cholesterol fetal stress fetal adrenal dehydroepiandrosterone sulphate |
|
|